Orthofix Medical Inc.
3451 Plano Parkway
Lewisville, Texas 75056
November 22, 2022
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Industrial Applications and Services
100 F Street, N.E.
Washington, D.C. 20549
Re: | Orthofix Medical Inc. |
Registration Statement on Form S-4 (File No. 333-268234)
Request for Acceleration of Effective Date
Dear Ms. Abby Adams:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Orthofix Medical Inc. (the Company) hereby respectfully requests that the U.S. Securities and Exchange Commission accelerate the effective date and time of the above referenced Registration Statement on Form S-4 (the Registration Statement) and declare the Registration Statement effective as of 5:30 p.m. Eastern Time on November 22, 2022, or as soon thereafter as practicable.
The Company requests that it be notified of such effectiveness by a telephone call to Joseph E. Gilligan of Hogan Lovells US LLP at (202) 637-5945.
[Signature page follows]
Sincerely, | ||
Orthofix Medical Inc. | ||
By: | /s/ Kimberley A. Elting | |
Kimberley A. Elting | ||
Chief Legal and Development Officer and President, Global Orthopedics |